Published in Infect Immun on June 01, 1976
Papovaviral persistent infections. Microbiol Rev (1982) 1.17
Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clin Vaccine Immunol (2007) 0.94
Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults. J Virol (2013) 0.86
The association of viruses with urveal melanoma. Trans Am Ophthalmol Soc (1979) 0.80
BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection. World J Transplant (2016) 0.75
Application of a microtechnique to viral serological investigations. J Immunol (1962) 51.33
New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet (1971) 12.13
A SPECIFIC COMPLEMENT-FIXING ANTIGEN PRESENT IN SV40 TUMOR AND TRANSFORMED CELLS. Proc Natl Acad Sci U S A (1963) 10.72
Prevalence in England of antibody to human polyomavirus (B.k.). Br Med J (1973) 3.34
Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med (1962) 3.32
Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med (1972) 3.09
De novo malignant tumors in organ transplant recipients. Transplant Proc (1971) 3.03
Human papovavirus, BK strain: biological studies including antigenic relationship to simian virus 40. J Virol (1973) 2.54
High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis (1973) 2.40
Human polyomavirus infection in renal allograft recipients. Br Med J (1973) 2.32
A human papovavirus (B.K.), biological properties and seroepidemiology. Ann Clin Res (1973) 2.21
Papova virus in urine after renal transplantation. Nature (1973) 2.17
Malignant transformation of BHK21 clone 13 cells by BK virus--a human papovavirus. Proc Natl Acad Sci U S A (1973) 2.01
Isolation of papovavirus from brain tumor and urine of a patient with Wiskott-Aldrich syndrome. J Natl Cancer Inst (1974) 2.00
Studies of the antigenic relationships of the new human papovaviruses by electron microscopy agglutination. Infect Immun (1973) 1.84
SV40 neutralizing antibodies in sera of US residents without history of polio immunization. Nature (1971) 1.77
Malignant transformation of hamster kidney cells by BK virus. J Virol (1975) 1.76
Comparison of two human papovaviruses with simian virus 40 by structural protein and antigenic analysis. J Virol (1974) 1.76
The oncogenic DNA viruses: a review of in vitro transformation studies. Annu Rev Microbiol (1968) 1.69
The presence of antibodies in human serum to early (T) adenovirus antigens. Proc Natl Acad Sci U S A (1967) 1.67
Sarcoma in a hamster inoculated with BK virus, a human papovavirus. J Natl Cancer Inst (1975) 1.65
Subacute sclerosing panencephalitis: a review. Curr Top Microbiol Immunol (1972) 1.41
Relationship of polyoma virus and tumor in vivo. Virology (1960) 1.34
Induced latent infection of monkeys with vacuolating SV-40 Papova virus. Virus in kidneys and urine. Proc Soc Exp Biol Med (1962) 1.30
Isolation and characterization of a papovavirus from human urine. Proc Soc Exp Biol Med (1974) 1.29
Occurrence of BK virus and BK virus-specific antibodies in the urine of patients receiving chemotherapy for malignancy. Infect Immun (1975) 1.18
Passive hemagglutinating antibodies in cerebrospinal fluids in herpesvirus hominis encephalitis. 1. Proc Soc Exp Biol Med (1972) 1.16
Evidence for an SV40-related papovavirus infection of man. Am J Epidemiol (1972) 1.14
Evidence of chronic persistent infections with polyomaviruses (BK type) in renal transplant recipients. Arch Virol (1975) 1.12
Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol (1974) 1.11
Experimental infection of rhesus with simian virus 40 (SV40). Proc Soc Exp Biol Med (1969) 1.08
Simian virus 40-related antigens in three human meningiomas with defined chromosome loss. Proc Natl Acad Sci U S A (1975) 1.03
Search for BK and SV40 virus reactivation in renal transplant recipients. Transplantation (1974) 1.01
Virus-induced tumor antigens. Curr Top Microbiol Immunol (1967) 0.95
Development of S and T antigens and oncogenicity in hamster embryonic cell lines exposed to SV40. Virology (1968) 0.92
Antibodies reacting to Simian virus 40 T antigen in human sera. J Natl Cancer Inst (1973) 0.89
A summary of the status of de novo cancer in transplant recipients. Transplant Proc (1972) 0.88
Serologic evidence for a simian-virus-40-like infection of man. J Natl Cancer Inst (1972) 0.84
Investigation of human malignant tumors in India for simian virus 40 etiology. J Natl Cancer Inst (1969) 0.83
Presence of antibodies to simian virus 40 (SV40) T antigen in rhesus monkeys infected experimentally or naturally with SV40. Proc Soc Exp Biol Med (1968) 0.80
Development of antibodies against viral and tumor antigens of papovavirus SV40 in monkeys. Proc Soc Exp Biol Med (1967) 0.79
Production of antibodies to papovavirus SV40 tumor antigen in African green monkeys. Proc Soc Exp Biol Med (1967) 0.79
Human herpes simplex virus infections. Adv Neurol (1974) 0.76
Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med (1976) 9.68
Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med (1981) 7.53
Breast cancer (1) N Engl J Med (1992) 4.79
Oncogenic response of rat skin, lungs, and bones to vinyl chloride. Cancer Res (1971) 4.39
Overview of the main outcomes in breast-cancer prevention trials. Lancet (2003) 4.31
Results of a breast-cancer-surgery trial compared with observational data from routine practice. Lancet (1996) 3.78
Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med (1977) 3.45
Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol (2001) 3.45
Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol (1994) 2.71
Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer (1982) 2.71
In vivo preservation of the hybrid layer by chlorhexidine. J Dent Res (2007) 2.65
Association between hepatitis C virus and mixed cryoglobulinemia [see comment]. Clin Exp Rheumatol (1992) 2.43
Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer (1981) 2.40
The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance. Cancer (1977) 2.33
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst (1990) 2.25
Plaque dissociation of herpes simplex viruses: biochemical and biological characters of the viral variants. Intervirology (1977) 2.23
Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis. Proc Soc Exp Biol Med (1970) 2.20
Early events in the infection of permissive cells with simian virus 40: adsorption, penetration, and uncoating. J Virol (1970) 2.18
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res (1996) 2.17
GOK: a gene at 11p15 involved in rhabdomyosarcoma and rhabdoid tumor development. Cancer Res (1997) 2.11
Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol (1985) 2.09
Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene (2000) 2.08
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst (1994) 2.06
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results. Eur J Cancer Clin Oncol (1986) 2.05
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell (2000) 1.98
Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc Natl Acad Sci U S A (2001) 1.96
Limitations in bonding to dentin and experimental strategies to prevent bond degradation. J Dent Res (2011) 1.92
Granzyme B is inhibited by the cowpox virus serpin cytokine response modifier A. J Biol Chem (1995) 1.88
Malignant transformation of hamster kidney cells by BK virus. J Virol (1975) 1.76
Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer (1978) 1.75
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer (1976) 1.75
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68
Immortalized myeloid suppressor cells trigger apoptosis in antigen-activated T lymphocytes. J Immunol (2000) 1.68
Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer. Eur J Cancer (1998) 1.68
Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer (1983) 1.65
Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions. Cancer Res (1994) 1.63
Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer. J Natl Cancer Inst (1997) 1.60
Transcellular transactivation by the human immunodeficiency virus type 1 tat protein. J Virol (1991) 1.57
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer. J Nucl Med (1998) 1.53
Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res (2001) 1.52
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat (1985) 1.51
Isolated detection of cryptococcal polysaccharide antigen in cerebrospinal fluid samples from patients with AIDS. Clin Infect Dis (1996) 1.50
Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg (1983) 1.50
Are surgical adjuvant trials altering the course of breast cancer? Semin Oncol (1978) 1.49
Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer (1999) 1.48
Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer (1987) 1.48
Effect of tamoxifen on measurements of hemostasis in healthy women. Arch Intern Med (1996) 1.46
Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol (1984) 1.46
Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer (2001) 1.44
Drop-outs in tamoxifen prevention trials. Lancet (1999) 1.44
Selective inhibition of a nuclear RNA polymerase in cells infected with frog virus. Nature (1970) 1.44
Proceedings: The value of staging laparotomy in non-Hodgkin's lymphomas (with emphasis on the histiocytic type). Cancer (1974) 1.43
Analysis of local and regional recurrences in breast cancer after conservative surgery. Ann Oncol (2009) 1.43
Surgical approach to internal mammary lymph node biopsy. J Am Coll Surg (2001) 1.42
Parvovirus b19 DNA is commonly harboured in human skin. Dermatology (2010) 1.41
Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO). Breast Cancer Res Treat (2009) 1.41
Facial nerve neuromas: diagnosis and management. Am J Otol (1995) 1.40
p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst (1993) 1.39
Breast cancer (2). N Engl J Med (1992) 1.39
Acute depression from isotretinoin. Another case. J Eur Acad Dermatol Venereol (2005) 1.38
Retention magnets in guiding plates of distal-extension removable partial dentures. J Prosthet Dent (1988) 1.37
Interaction between papova-like virus and paramyxovirus in human brain cells: a hypothesis. Nature (1970) 1.35
N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res (1993) 1.33
Antibody-guided three-step therapy for high grade glioma with yttrium-90 biotin. Eur J Nucl Med (1999) 1.32
Histoplasmosis capsulati and duboisii in Europe: the impact of the HIV pandemic, travel and immigration. Eur J Epidemiol (1994) 1.31
Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg (1975) 1.29
Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res (1994) 1.29
Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res (1981) 1.29
Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region. Oncogene (1999) 1.28
Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg (1985) 1.27
Biologic and clinicopathologic factors as indicators of specific relapse types in node-negative breast cancer. J Clin Oncol (1995) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). Vaccine (2001) 1.26
Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J Clin Oncol (1993) 1.25
Integrated and free viral DNA in hamster tumors induced by BK virus. Proc Natl Acad Sci U S A (1980) 1.24
Comparison of radioguided excision with wire localization of occult breast lesions. Br J Surg (1999) 1.22
Multimodal treatment in operable breast cancer: five-year results of the CMF programme. Br Med J (Clin Res Ed) (1981) 1.21
The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood (1995) 1.21
Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. Ann Oncol (2002) 1.20
Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J Clin Microbiol (1989) 1.20
The BFRF1 gene of Epstein-Barr virus encodes a novel protein. J Virol (2000) 1.20
Osseointegration enhanced by chemical etching of the titanium surface. A torque removal study in the rabbit. Clin Oral Implants Res (1997) 1.19
Nipple-sparing mastectomy: risk of nipple-areolar recurrences in a series of 579 cases. Breast Cancer Res Treat (2008) 1.19
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. Arterioscler Thromb Vasc Biol (1997) 1.19
BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors. Adv Virus Res (1998) 1.19
Two end-to-side neurorrhaphies and nerve graft with removal of the epineural sheath: experimental study in rats. Br J Plast Surg (1994) 1.19
Chlamydial infections in Italy. Sex Transm Dis (1982) 1.18
Breast cancer (3). N Engl J Med (1992) 1.18
Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples. Proc Natl Acad Sci U S A (1998) 1.17